Welcome to ‘BoraSphere’
In these unique times, the call for education and dialogue within the Pharma Community and its contract manufacturing partners has never been more apparent or necessary. Pharma’s vital role can hardly be understated during the COVID-19 pandemic and the role that their contract manufacturing partners play in providing much needed drugs.
It’s time we expand our dialog and education
Pharma’s relationship with its contract partners is growing more complex, day by day. There was a time when the relationship between contract manufacturers and Pharma was a simple contractual matter; not much beyond determining price, scope, and terms.
But now in 2020, with 26% of the world’s drugs being manufactured by contract manufacturers, the nature of the relationship is fast becoming more integrated and strategic than ever.
Strategic outsourcing of contract manufacturing depends on a successful peer-to-peer relationship between partners that few commercial relationships can match. Product quality and cost-efficient development depend on it. Bora’s success as a drug developer, contract manufacturer and packager is predicated on it, and we’d like to share ideas on how to make these relationships even more successful.
To spark the conversation, we are excited to introduce our new blog series BoraSphere – a place where drug developers can come for the education and ideas to successfully execute today’s most ambitious drug development and commercialization.
What to expect from our series
Each month we’ll publish a new blog offering a fresh point of view on development and manufacturing trends challenging the industry. We’ll also offer insights into how our customers are leveraging Bora’s capabilities and global operations to advance their drug programs.
Upcoming topics will cover tech transfer best practices, quality systems, top considerations for selecting cGMP facilities, flexible scaling, faster commercialization routes, optimized dose form processing techniques and more.
We’ll also offer insight and tips from Bora’s team on what is working best to increase manufacturing quality and achieve better development outcomes across the board, from the lab, through the factory, to the patient.
We’re hoping our blog series will educate you, give you access to new science, capabilities and ideas as well as help you get to know Bora better. We are all in this together to speed production, lower costs, provide better access, and drive innovation.
